Therapeutic Asset Ratings

5,098 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
25-HYDROXYCALCIFEROL Prostate Adenocarcinoma	University of Ilorin Teaching Hospital	P3	B (60)
25-HYDROXYCALCIFEROL Neoplasm	University of Ilorin Teaching Hospital	P3	B (60)
2-CHLORO-N6-(3-IODOBENZYL)ADENOSINE-5'-N-METHYLURONAMIDE Cirrhosis Of Liver	Can-Fite BioPharma	P3	B (60)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Brain Neoplasm	Children's Cancer Hospital Egypt 57357	P3	B (60)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Inflammatory Disease	University Tunis El Manar	P3	B (60)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Morbid Obesity	Cairo University	P3	B (60)
4H-1-BENZOPYRAN-4-ONE, 7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-, (S)- Pelvic Congestion Syndrome	Pirogov Russian National Research Medical University	P3	B (60)
6-(3-(4-(O-METHOXYPHENYL)-1-PIPERAZINYL)PROPYLAMINO)-1,3-DIMETHYLURACIL Ischemic Stroke	Second Affiliated Hospital, School of Medicine, Zhejiang University	P3	B (60)
Abacavir Amyotrophic Lateral Sclerosis	Macquarie University, Australia	P3	B (60)
Abatacept Recombinant Juvenile Myelomonocytic Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P3	B (60)
Abemaciclib Chemotherapy-Induced Toxicity	Eli Lilly and Company	P3	B (60)
Abemaciclib Melanoma, Cutaneous Malignant, Susceptibility To, 3	Eli Lilly and Company	P3	B (60)
Abemaciclib Microcephaly 12, Primary, Autosomal Recessive	Eli Lilly and Company	P3	B (60)
Abemaciclib Estrogen-Receptor Positive Breast Cancer	Jonsson Comprehensive Cancer Center	P3	B (60)
Abiraterone Chemotherapy-Induced Toxicity	Eli Lilly and Company	P3	B (60)
Abiraterone Melanoma, Cutaneous Malignant, Susceptibility To, 3	Eli Lilly and Company	P3	B (60)
Abiraterone Microcephaly 12, Primary, Autosomal Recessive	Eli Lilly and Company	P3	B (60)
Abiraterone Differentiated Thyroid Carcinoma	Exelixis	P3	B (60)
Abiraterone Hepatocellular Carcinoma	Exelixis	P3	B (60)
Abiraterone Pancreatic Neuroendocrine Tumor	Exelixis	P3	B (60)
Abiraterone Renal Cell Carcinoma	Exelixis	P3	B (60)
Abiraterone Urinary System Neoplasm	Eli Lilly and Company	P3	B (60)
Acetylcysteine Beta Thalassemia	Tanta University	P3	B (60)
Acoramidis Cardiomyopathy	Eidos Therapeutics, a BridgeBio company	P3	B (60)
Acoramidis Heart Disorder	Eidos Therapeutics, a BridgeBio company	P3	B (60)

Showing 2626 to 2650 of 5,098 assets

PreviousPage 106 of 204Next